GNMX vs GNOM

Corgi Genomics & Precision Medicine ETF against Global X Genomics & Biotechnology ETF: cost, size, returns, what they hold and how much of it is the same.

Overlap by weight
48%
29 shared positions
Fee gap
15 bp
GNMX is cheaper
1-year return gap
—
Larger fund
GNOM
$110M

Side by side

GNMXGNOM
FundCorgi Genomics & Precision Medicine ETFGlobal X Genomics & Biotechnology ETF
IssuerCorgiGlobal X
CategoryBiotech & Health InnovationBiotech & Health Innovation
Expense ratio0.35%0.50%
Assets$1.3M$110M
Average daily dollar volume$114K$2.5M
ListedMay 5, 2026Apr 5, 2019
FrenzyCap score4149
1-month return+1.1%−0.8%
3-month return+26.0%+25.2%
Year to date—+51.2%
1-year return—+54.3%
30-day volatility37.7%41.3%
Worst drawdown, 1 year−9.0%−18.2%
Trailing 12-month yield—0.94%
Holdings5952
Top 10 weight49.0%55.6%
Look-through P/E——
Holdings vs fair value+2.9%+0.4%
Holdings above 200-day average86%75%
Net flow, latest 3 reported months+$1.3M thru Jun 2026+$1.4M thru May 2026
30-day implied volatility—38.0%
Holdings as ofas of Oct 21, 2026issuer dataas of Oct 21, 2026issuer data

Returns are price returns and exclude distributions. Flows are each fund's own latest reported months and may not cover the same period.

Largest shared holdings

52% of GNMX · 72% of GNOM
HoldingGNMXGNOM
MRNA10.77%12.32%
ILMN4.93%6.04%
GH3.43%5.19%
VRTX5.82%3.34%
TXG3.23%6.22%
TWST2.44%6.38%
TECH2.11%3.46%
QGEN2.06%3.49%
CDNA2.02%2.36%
BMRN1.84%2.85%
CAI1.37%2.83%
VCYT1.29%2.62%
ARWR1.27%2.22%
CRSP1.25%2.49%
BEAM0.84%1.68%
SRPT0.82%1.35%
QURE0.81%0.92%
PSNL1.19%0.80%
WGS0.73%1.29%
NTLA0.66%0.95%
RARE0.57%1.08%
PACB0.60%0.42%
MYGN0.51%0.35%
FLGT0.50%0.29%
PRME0.44%0.26%

Sector mix of the stock holdings

SectorGNMXGNOMGap
Health Care74.7%80.4%−5.7%
Technology20.7%14.7%+6.0%
Industrials2.2%0.0%+2.2%

More: full overlap table · GNMX holdings · GNOM holdings

Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.